Shirley Tang

Shirley Tang's research focuses on molecular mechanisms in cancer, particularly the role of the Fanconi Anemia DNA-repair pathway and microRNAs (small regulatory RNA molecules) in lung cancer development. Her work often uses mouse models with mutations in the p53 tumor-suppressor gene to study how these pathways influence tumor formation and response to treatment. This research is aimed at understanding cancer biology at the molecular level, which could inform future diagnostic or therapeutic approaches.

Publication output has fluctuated over the past decade, with a peak in 2019 and generally modest, uneven activity averaging about 1-2 papers per year in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026